Biomerics Welcomes Tyler Reed as President of Micro Metals Division

Biomerics, a recognized leader in contract manufacturing for the interventional medical device sector, has recently announced that Tyler Reed will take on the role of President for its Micro Metals Division. This strategic appointment comes amid the company's ongoing efforts to bolster operational efficiency and enhance service delivery to its global customer base.

In a statement, Arun Mohan, the CEO of Biomerics, expressed confidence in Reed's capabilities, highlighting his extensive experience managing large-scale manufacturing operations. Mohan emphasized that Tyler's track record includes achieving double-digit profitable growth and successfully executing global lean manufacturing transformations. Reed has also garnered considerable attention for his ability to lead manufacturing site startups, operational turnarounds, and to cultivate high-performance teams focused on aligning culture with strategic execution.

Reed remarked, "I am honored to lead Biomerics' Micro Metals Division into its next chapter. My primary focus will be on enhancing efficiency, optimizing resource utilization, and driving employee engagement and retention. I aim to align our efforts with the strategic pillars of customer excellence, innovation, and manufacturing excellence."

As the president, Reed's responsibilities will encompass managing key areas such as commercial operations, engineering, and ensuring operational excellence throughout the division. He will work towards improving customer satisfaction, delivery performance, and implementing manufacturing automation measures to optimize costs and elevate facility performance.

About Biomerics

Biomerics has been a trusted partner in the medical device industry since its inception in 1994. It is renowned for its vertically integrated approach, serving 20 of the top 30 medical device OEMs globally. Their expertise includes engineering design and development, technology transfer manufacturing services, and comprehensive contract manufacturing services inclusive of sterilization and packaging. With facilities across the United States, Costa Rica, and the Dominican Republic, Biomerics addresses both immediate and long-term needs of its clients.

Biomerics stands out with its diverse portfolio, which includes performance materials, interventional medical plastics, complex extrusions, and specialized medical device manufacturing services such as micromachining of metals, laser processing, balloon manufacturing, advanced catheter production, and micro-assembly solutions. The company operates under a certified ISO 13485:2016 quality system and is FDA registered, adhering to stringent regulations under FDA 21 CFR Part 820.

The company is committed to pushing the boundaries of innovation within the medical device industry, and Reed's leadership is poised to accelerate this mission. As Biomerics continues to advance, customers can expect a steadfast commitment to quality, responsiveness, and the highest standards of service in medical device manufacturing.

By appointing a leader of Reed's caliber, Biomerics underscores its dedication to excellence and its vision for future growth within the evolving landscape of medical technology. With Reed at the helm of the Micro Metals Division, the company is well-positioned to enhance its operational efficiencies and drive product innovations that meet the needs of an increasingly demanding market.